ZokinvyActive Ingredient(s): Lonafarnib
FDA Approved: * November 20, 2020
Pharm Company: * EIGER BIOPHARMS
Category: Genetic Disorders
Lonafarnib, sold under the brand name Zokinvy, is a medication used to reduce the risk of death due to Hutchinson-Gilford progeria syndrome and for the treatment of certain processing-deficient progeroid laminopathies in people one year of age and older. The most common side effects included nausea vomiting, headache ,diarrhea, infection, decreased appetite and fatigue. Lonafarnib was approved for medical use in the United States in Nov... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.